[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Commentary
Health Policy
April 27, 2020

Affordable Biologics for All

Author Affiliations
  • 1School of Health Policy and Management, Faculty of Health, York University, Toronto, Ontario, Canada
  • 2Department of Family and Community Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
JAMA Netw Open. 2020;3(4):e204753. doi:10.1001/jamanetworkopen.2020.4753

To paraphrase something that Mark Twain is alleged to have said, “Everybody talks about drug prices, but nobody does anything about them.” The last part of the paraphrase is not quite accurate, but to date, none of the major federal proposals to lower drug prices have been enacted, and state legislation, such as the California Preserving Access to Affordable Drugs Act, is under legal challenge from the pharmaceutical industry. Especially hard hit by high prices are uninsured patients who pay the list price. Cost-related treatment nonadherence in low-income US patients was almost 25% according to the results of the Commonwealth Fund 2014 International Health Policy Survey of Older Adults.1

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words